Pacific Biosciences

$30.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.57 (-12.80%) Today
-$0.35 (-1.11%) As of 1:40 PM UTC after-hours

Why Robinhood?

You can buy or sell PACB and other stocks, options, and ETFs commission-free!

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. The listed name for PACB is Pacific Biosciences of California, Inc. Common Stock.

CEO
Christian O. Henry
Employees
404
Headquarters
Menlo Park, California
Founded
2000
Market Cap
6.25B
Price-Earnings Ratio
210.29
Dividend Yield
—
Average Volume
7.28M
High Today
$35.68
Low Today
$30.52
Open Price
$35.68
Volume
7.09M
52 Week High
$53.69
52 Week Low
$2.20

PACB News

BenzingaFeb 24

SoftBank-Backed Ride-Hailing Company Didi Beefs Up Europe Entry Plan

Bloomberg (Bloomberg) -- SoftBank Group Corp. plans to expand its investments in the biotech and health-care sector, opening up a new front in its growing asse

PACB Earnings

-$0.19
-$0.00
$0.18
$0.37
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

SCHR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure